DTP Branches and Offices
Last Updated: 07/08/21
Approved Cancer Treatment Drugs Developed with DTP Involvement
Year | Drug Name(s) | Year | Drug Name(s) |
---|---|---|---|
2018 | Moxetumomab pasudotox-tdfk | 1982 | Streptozotocin (NSC 85998) |
2015 | Dinutuximab (Unituxin, NSC 764038) Ecteinascidin 743 (NSC 648766) |
1979 | Daunorubicin (NSC 82151) |
2012 | Omacetaxine (homoharringtonine, NSC 141633) | 1978 | Cisplatin (cis-platinum) (NSC 119875) |
2010 | Eribulin (NSC 707389) Sipuleucel-T (NSC 720270) |
1977 | Carmustine (BCNU) (NSC 409962) |
2009 | Romidepsin (NSC 630176) Pralatrexate (NSC 713204) |
1976 | 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosurea (CCNU) (NSC 9037) |
2004 | Azacitidine (NSC 102816) Cetuximab (NSC 632307) |
1975 | Dacarbazine (NSC 45388) |
2003 | Bortezomib (NSC 681239) | 1974 | Doxorubicin (NSC 123127) Mitomycin C (NSC 26980) |
2000 | Entinostat (706995) | 1973 | Bleomycin (NSC 125066) |
1998 | Denileukin diftitox (NSC 697979) | 1970 | Floxuridine (FUDR) (NSC 27640) Mithramycin (NSC 24559) Mitotane (o-p'-DDD) (NSC 38721) |
1996 | Polifeprosan 20 with carmustine implant (NSC 714372) Topotecan (NSC 609699) |
1969 | Cytarabine (ARA-C) (NSC 63878) Procarbazine (NSC 77213) |
1995 | All-t-retinoic acid (NSC 122758) | 1967 | Hydroxyurea (NSC 32065) |
1992 | 2-Chlorodeoxyadenosine (NSC 105014) Paclitaxel (NSC 125973) Teniposide (NSC 122819) |
1966 | Pipobroman (NSC 25154) Thioguanine (NSC 752) |
1991 | Fludarabine Phosphate (NSC 312887) Pentostatin (NSC 218321) |
1964 | Melphalan (NSC 8806) Actinomycin D (NSC 3053) |
1990 | Hexamethylmelamine (NSC 13875) Levamisole (NSC 177023) |
1963 | Vincristine (NSC 67574) |
1989 | Carboplatin (NSC 241240) | 1962 | Fluorouracil (NSC 19893) |
1988 | Ifosfamide (NSC 109724) | 1961 | Vinblastine (NSC 49842) |
1987 | Mitoxantrone (NSC 301739) | 1959 | Cyclophosphamide (NSC 26271) Thiotepa (NSC 6396) |
1983 | Etoposide (NSC 141540) | 1957 | Chlorambucil (NSC 3088) |